Could Well Health Stock Help You Become a Millionaire?

Well Health stock has faltered lately, but revenue continues to grow rapidly as the company continues to digitize health care industries.

| More on:
telehealth stocks

Image source: Getty Images

Not too long ago, Well Health Technologies Corp. (TSX:WELL) was riding high on pandemic-era stock market optimism. Today, this optimism for Well Health Technologies stock has waned as the macro-economic environment has deteriorated, and investors are feeling more risk averse.

But I’m keeping my eyes on the long-term, as there are many reasons to believe in Well Health.

Well Health is a disruptor in the health care industry

Those of you who have followed Well Health stock over the last few years know that it has been volatile. In truth, this volatility has largely been a function of investor sentiment. This is because emotions have run high, as this company promises to majorly disrupt the health care industry. And with this kind of disruption, potential rewards are very significant.

The Canadian healthcare system is especially sorely lacking in technology. This is what Well Health Technologies is out to change. The benefits of technology in the health system are multi-faceted. From lower wait times, improved patient outcomes and specialized and targeted treatment, to a lower administrative burden on doctors.

If you are not convinced of Well Health’s value proposition yet, read on to see proof of the increasing acceptance of its value. These are the reasons I think investing in Well Health stock could help you become a millionaire.

The proof is in the results

Well Health has been delivering record results for many quarters now. In its latest quarter, Q3 2023, the company reported a 40% increase in revenue to $204.5 million. This includes a 27% increase in Canadian patient services revenue and a 52% increase in USA patient care services. Organic growth was 16% and the rest of the growth was due to acquisitions.

As a result of this record performance, the company increased its revenue guidance again, bringing it closer to its target of reaching $1 billion in revenue. In fact, the company now expects revenue of $755 million to $765 million in 2023 and more than $900 million in 2024. This equates to a 34% revenue growth rate in 2023 and a more than 18% revenue growth rate in 2024. Note that these estimates do not include unannounced acquisitions, and management has stressed that its pipeline is very strong.

So, assuming this revenue guidance is achieved, the company will have grown from revenue of $10 million in 2018 to $900 million in 2024. That’s 8,400% revenue growth in six short years.

Well Health stock’s potential clouded in short term

I would be amiss if I didn’t mention the elephant in the room – Well Health is not profitable and is heavily investing in growth. This is enough to keep many smart investors away, and I understand this. However, if we want millionaire potential, we often have to buy despite this.

When I recommend Well Health Technologies stock, I do it with two key assumptions. The first is that investors understand the elevated risk of a company that’s currently operating at a net loss. This means investing a small portion of total funds into this type of stock.

The second assumption is that Well Health’s business is one that has staying power because it’s sorely needed and, thus, the company is increasingly building its network, scale, and expertise. This will result in continued growth for the company. And as the healthcare industry improves, this mutually beneficial relationship will continue to grow stronger.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has a position in Well Health Technologies. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Tech Stocks

Group of people network together with connected devices
Tech Stocks

Billionaires Are Selling NVIDIA and Picking Up This TSX Stock

Billionaires are selling NVIDIA (NASDAQ:NVDA), but buying Shopify Inc (TSX:SHOP).

Read more »

Value for money
Tech Stocks

3 Cheap TSX Stocks to Buy as the Canadian Market Continues to Rally

Given their discounted stock prices and healthy growth prospects, these three TSX stocks offer excellent buying opportunities for long-term investors.

Read more »

stock analysis
Tech Stocks

Billionaires Are Selling NVIDIA and Picking up This TSX Stock Instead

It looks like some billionaires are dropping their shares of NVIDIA. So, what are they picking up in its place?

Read more »

nvidia headquarters with nvidia sign in front
Tech Stocks

Why Nvidia Stock Surged After the Fed Rate Cut

An interest rate cut can be a growth stimulant for a variety of businesses in the market, including semiconductor giants.

Read more »

top TSX stocks to buy
Tech Stocks

2 Stocks That Could Transform $100,000 Into $1 Million

To become a millionaire, you need to harness the power of compounding by staying invested for a longer term in…

Read more »

online shopping
Tech Stocks

PayFare Stock: Can This Undervalued Stock Make You a Millionaire One Day?

These hidden gems provide opportunities to buy low and, hopefully, sell high.

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

2 Beaten-Down AI Stocks Every Canadian Investor Should Watch

Investors with a high risk appetite can consider investing in AI stocks such as UiPath and Hive to benefit from…

Read more »

TFSA and coins
Tech Stocks

Here’s the Average TFSA Balance in 2024

Here's why investors should hold quality stocks such as Microsoft in their TFSA and benefit from outsized gains in 2024…

Read more »